Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 December 2003, Vol. 102, No. 12, pp. 3927-3933.
Prepublished online as a Blood First Edition Paper on August 7, 2003; DOI 10.1182/blood-2003-05-1522.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-05-1522v1
102/12/3927    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weigel-Kelley, K. A.
Right arrow Articles by Srivastava, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weigel-Kelley, K. A.
Right arrow Articles by Srivastava, A.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Red Cells
Right arrow Cell Adhesion and Motility
Right arrow Gene Therapy
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

GENE THERAPY

{alpha}5{beta}1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of {beta}1 integrin for viral entry

Kirsten A. Weigel-Kelley, Mervin C. Yoder, and Arun Srivastava

From the Departments of Microbiology and Immunology, and Biochemistry and Molecular Biology, Indiana University School of Medicine; Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine; Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN; and Walther Oncology Center, Walther Cancer Institute, Indiana University School of Medicine, Indianapolis, IN.

Replication of the pathogenic human parvovirus B19 is restricted to erythroid progenitor cells. Although blood group P antigen has been reported to be the cell surface receptor for parvovirus B19, a number of nonerythroid cells, which express P antigen, are not permissive for parvovirus B19 infection. We have documented that P antigen is necessary for parvovirus B19 binding but not sufficient for virus entry into cells. To test whether parvovirus B19 utilizes a cell surface coreceptor for entry, we used human erythroleukemia cells (K562), which allow parvovirus B19 binding but not entry. We report here that upon treatment with phorbol esters, K562 cells become adherent and permissive for parvovirus B19 entry, which is mediated by {alpha}5{beta}1 integrins, but only in their high-affinity conformation. Mature human red blood cells (RBCs), which express high levels of P antigen, but not {alpha}5{beta}1 integrins, bind parvovirus B19 but do not allow viral entry. In contrast, primary human erythroid progenitor cells express high levels of both P antigen and {alpha}5{beta}1 integrins and allow {beta}1 integrin–mediated entry of parvovirus B19. Thus, in a natural course of infection, RBCs are likely exploited for a highly efficient systemic dissemination of parvovirus B19.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
S. Wong, N. Zhi, C. Filippone, K. Keyvanfar, S. Kajigaya, K. E. Brown, and N. S. Young
Ex Vivo-Generated CD36+ Erythroid Progenitors Are Highly Permissive to Human Parvovirus B19 Replication
J. Virol., March 1, 2008; 82(5): 2470 - 2476.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. Waldman and J. B. Kopp
Parvovirus B19 and the Kidney
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(Supplement_1): S47 - S56.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J. R. Kerr and N. Boschetti
Short regions of sequence identity between the genomes of human and rodent parvoviruses and their respective hosts occur within host genes for the cytoskeleton, cell adhesion and Wnt signalling
J. Gen. Virol., December 1, 2006; 87(12): 3567 - 3575.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Lupescu, C.-T. Bock, P. A. Lang, S. Aberle, H. Kaiser, R. Kandolf, and F. Lang
Phospholipase A2 Activity-Dependent Stimulation of Ca2+ Entry by Human Parvovirus B19 Capsid Protein VP1
J. Virol., November 15, 2006; 80(22): 11370 - 11380.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Asokan, J. B. Hamra, L. Govindasamy, M. Agbandje-McKenna, and R. J. Samulski
Adeno-Associated Virus Type 2 Contains an Integrin {alpha}5{beta}1 Binding Domain Essential for Viral Cell Entry.
J. Virol., September 1, 2006; 80(18): 8961 - 8969.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Esfandiarei, A. Suarez, A. Amaral, X. Si, M. Rahmani, S. Dedhar, and B. M. McManus
Novel Role for Integrin-Linked Kinase in Modulation of Coxsackievirus B3 Replication and Virus-Induced Cardiomyocyte Injury
Circ. Res., August 18, 2006; 99(4): 354 - 361.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Norja, K. Hokynar, L.-M. Aaltonen, R. Chen, A. Ranki, E. K. Partio, O. Kiviluoto, I. Davidkin, T. Leivo, A. M. Eis-Hubinger, et al.
Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue
PNAS, May 9, 2006; 103(19): 7450 - 7453.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Lopez-Bueno, M.-P. Rubio, N. Bryant, R. McKenna, M. Agbandje-McKenna, and J. M. Almendral
Host-Selected Amino Acid Changes at the Sialic Acid Binding Pocket of the Parvovirus Capsid Modulate Cell Binding Affinity and Determine Virulence
J. Virol., February 1, 2006; 80(3): 1563 - 1573.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
Y. Fujii, S.-i. Numata, Y. Nakamura, T. Honda, K. Furukawa, T. Urano, J. Wiels, M. Uchikawa, N. Ozaki, S.-i. Matsuo, et al.
Murine glycosyltransferases responsible for the expression of globo-series glycolipids: cDNA structures, mRNA expression, and distribution of their products
Glycobiology, December 1, 2005; 15(12): 1257 - 1267.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Marttila, D. Persson, D. Gustafsson, M. K. Liszewski, J. P. Atkinson, G. Wadell, and N. Arnberg
CD46 Is a Cellular Receptor for All Species B Adenoviruses except Types 3 and 7
J. Virol., November 15, 2005; 79(22): 14429 - 14436.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Munakata, T. Saito-Ito, K. Kumura-Ishii, J. Huang, T. Kodera, T. Ishii, Y. Hirabayashi, Y. Koyanagi, and T. Sasaki
Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection
Blood, November 15, 2005; 106(10): 3449 - 3456.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Kaufmann, A. A. Simpson, and M. G. Rossmann
The structure of human parvovirus B19
PNAS, August 10, 2004; 101(32): 11628 - 11633.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
A. Corcoran and S. Doyle
Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19
J. Med. Microbiol., June 1, 2004; 53(6): 459 - 475.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020